DGAP-News 533 0 Kommentare STADA: Executive Board gives a positive summary of 2012 at Annual General Meeting and adheres to the positive outlook till 2014 - Supervisory Board members approved - Seite 2

resolved a dividend of Euro 0.50 per STADA common share, which is by 35.1
percent significantly higher than the previous year, with the remaining
surplus being carried forward. The Executive Board and the Supervisory
Board were confirmed with a high level of approval. In addition, the
Executive Board made resolutions on the creation of a new authorized
capital and a new conditional capital as well as on the purchase and
utilization of treasury shares. The Annual General Meeting confirmed the
membership of all shareholder representatives in the Supervisory Board
- Dr. Martin Abend (Chairman)

- Dr. Eckhard Brüggemann

- Dr. K. F. Arnold Hertzsch

- Dieter Koch

- Constantin Meyer and

- Carl Ferdinand Oetker
for an additional five years. It was also resolved to revise the
remuneration of the Supervisory Board.

The wording of today's speech script of the Chairman of the Executive Board
as well as the exact voting results for all items on the agenda can be
found at STADA's website at www.stada.com/agm2013.

Additional information:
STADA Arzneimittel AG / Corporate Communications / Stadastrasse 2-18 /
61118 Bad Vilbel - Germany / Phone: +49 (0) 6101 603-113 / Fax: +49 (0)
6101 603-506 / E-mail: communications@stada.de
Or visit us in the Internet at www.stada.com.

End of Corporate News

---------------------------------------------------------------------

05.06.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------

Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications@stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime
Standard); Freiverkehr in Berlin, Hamburg, Hannover,
München, Stuttgart

End of News DGAP News-Service
---------------------------------------------------------------------
215014 05.06.2013

Seite 2 von 2

◄ Seite 1